Vontier Corporation (VNT)

Theseus Pharmaceuticals Revenue

Vontier had revenue of $773.50M in the quarter ending June 27, 2025, with 11.07% growth. This brings the company's revenue in the last twelve months to $3.04B, up 1.16% year-over-year. In the year 2024, Vontier had annual revenue of $2.98B, down -3.75%.

• Revenue (ttm): $3.04B
• Revenue Growth: +1.16%
• P/S Ratio: 1.99
• Revenue / Employee: $380,175
• Employees: 8,000
• Market Cap: 5.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.98B	-116.20M	-3.75%
Dec 31, 2023	3.10B	-89.20M	-2.80%
Dec 31, 2022	3.18B	193.70M	6.48%
Dec 31, 2021	2.99B	286.10M	10.58%
Dec 31, 2020	2.70B	-67.50M	-2.43%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.